ReviewDrug design, development and therapy2026
Advances in Research on Autophagy in Steroid-Induced Osteonecrosis of the Femoral Head: Dual Regulation of Its Beneficial and Detrimental Effects.
Review in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Steroid-induced osteonecrosis of the femoral head (SONFH) is a common and refractory clinical condition with a complex pathogenesis that remains incompletely understood. As a highly conserved intracellular degradation and recycling pathway, autophagy plays a dual regulatory role in the pathological process of SONFH: moderate activation of autophagy exerts protective effects by clearing damaged organelles and maintaining cellular homeostasis; conversely, excessive or dysfunctional autophagy aggravates cell injury and bone tissue destruction. This narrative review systematically summarizes the dynamics, mechanisms, and regulatory networks of autophagy in SONFH from the perspectives of both beneficial and detrimental autophagy, providing references for a deeper understanding of SONFH and the development of targeted therapies. Furthermore, we explore therapeutic strategies based on the dual nature of autophagy, including precise pharmacological modulation, restoration of autophagic-lysosomal function, combined treatment approaches, and the application of novel biomaterials and targeted delivery systems. By integrating current mechanistic insights and proposing stage-specific regulatory strategies, this review highlights the translational potential of autophagy modulation in SONFH and provides a theoretical foundation for future clinical interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.